CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 62 filers reported holding CRISPR THERAPEUTICS AG in Q3 2017. The put-call ratio across all filers is 1.87 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $388,356 | -12.5% | 8,556 | +8.2% | 0.12% | -7.5% |
| Q2 2023 | $443,842 | +24.9% | 7,906 | +0.6% | 0.13% | +18.8% |
| Q1 2023 | $355,326 | +14.2% | 7,856 | +2.6% | 0.11% | +3.7% |
| Q4 2022 | $311,216 | -40.6% | 7,656 | -4.5% | 0.11% | -41.9% |
| Q3 2022 | $524,000 | -2.4% | 8,020 | -9.3% | 0.19% | +0.5% |
| Q2 2022 | $537,000 | -13.5% | 8,840 | -10.6% | 0.18% | 0.0% |
| Q1 2022 | $621,000 | -24.7% | 9,890 | -9.2% | 0.18% | -11.9% |
| Q4 2021 | $825,000 | -34.0% | 10,890 | -2.5% | 0.21% | -30.7% |
| Q3 2021 | $1,250,000 | -30.1% | 11,170 | +1.1% | 0.30% | -24.8% |
| Q2 2021 | $1,788,000 | +44.3% | 11,045 | +8.6% | 0.40% | +18.5% |
| Q1 2021 | $1,239,000 | -9.8% | 10,170 | +13.4% | 0.34% | -17.3% |
| Q4 2020 | $1,373,000 | +73.8% | 8,970 | -5.0% | 0.41% | +37.9% |
| Q3 2020 | $790,000 | +18.4% | 9,445 | +4.1% | 0.30% | +15.1% |
| Q2 2020 | $667,000 | +73.7% | 9,075 | +0.3% | 0.26% | +41.5% |
| Q1 2020 | $384,000 | -6.1% | 9,045 | +34.6% | 0.18% | +10.2% |
| Q4 2019 | $409,000 | +752.1% | 6,720 | +397.8% | 0.17% | +690.5% |
| Q1 2019 | $48,000 | +242.9% | 1,350 | +170.0% | 0.02% | +110.0% |
| Q4 2018 | $14,000 | -36.4% | 500 | 0.0% | 0.01% | +25.0% |
| Q3 2018 | $22,000 | -42.1% | 500 | -23.1% | 0.01% | -42.9% |
| Q2 2018 | $38,000 | +442.9% | 650 | +52.9% | 0.01% | +366.7% |
| Q2 2017 | $7,000 | -22.2% | 425 | 0.0% | 0.00% | -40.0% |
| Q1 2017 | $9,000 | +28.6% | 425 | +30.8% | 0.01% | +25.0% |
| Q4 2016 | $7,000 | – | 325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |